Michael Kim is a Director in Baird’s Global Healthcare Investment Banking group, focusing on the BioPharma space. Michael joined Baird in 2015 and currently provides deal execution leadership on private and public equity offerings, mergers and acquisitions and other financial advisory services. Prior to joining Baird, Michael was a researcher in the Viral Pathogenesis and Evolution Section at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. Michael received his MBA from the Samuel Curtis Johnson Graduate School of Management at Cornell University and his B.S. in Biology and B.A. in the Late Imperial Russian History from the University of Virginia.